SBIO News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

SB

Volume

20.60K

Loading chart

SB

SBIOALPS Medical Breakthroughs ETF

SBIO

Pay with—

Available Balance0.00

SB

AUM

N/A

Volume

20.59K

Yield

2.34%

Chart Earnings News About Insider Filings

Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?The ALPS Medical Breakthroughs ETF (SBIO) is a passively managed healthcare ETF that tracks small-cap and mid-cap pharmaceutical and biotechnology stocks in Phase II or Phase III FDA clinical trials. With a 0.5% expense ratio, $243.54 million in assets, and 107 holdings, it has delivered 32.1% year-to-date returns and 82.83% over 12 months. However, it carries high risk with a beta of 0.74 and 30.54% standard deviation. The fund received a Zacks ETF Rank of 3 (Hold), with alternatives like VHT and XLV offering lower expense ratios.Zacks Investment Research · Sep 8, 2026

This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lagThis week’s ETF Wrap digs into the jump in biotech funds, as well as an “unusual” trend in U.S. small-cap stocks versus small-cap tech equities.MarketWatch · Feb 29, 2024

Inside Small-Cap's 3-Year Best Surge in Popularity: ETFs in FocusWall Street's newfound bullishness on small caps reflects a notable shift in market dynamics, with several analysts predicting continued growth.Zacks Investment Research · Jan 17, 2024

5 Market-Beating Sector ETFs of DecemberWall Street sizzled in December, with all three major indices touching a series of new highs.Zacks Investment Research · Dec 29, 2023

Best-Performing ETFs of Last WeekThe S&P 500 hit a new high for the year last week after the November jobs report and University of Michigan consumer survey data indicated a resilient economy and cooling inflation, triggering bets on a so-called soft-landing scenario.Zacks Investment Research · Dec 11, 2023

5 ETF Areas That Spooked Investors in OctoberAfter a downbeat September, October too remained volatile for Wall Street due to higher rates.Zacks Investment Research · Oct 30, 2023

5 Top-Performing Sector ETFs of Q2Wall Street is on track to end the second quarter on a positive note. The Nasdaq Composite Index has outperformed, gaining 10.9% since the start of April, while the S&P 500 and the Dow Jones are up 6.6% and 2%, respectively.Zacks Investment Research · Jun 29, 2023

Biotech ETFs Pop on M&A Resurgence2023 could be a year of heightened biotech dealmaking activityZacks Investment Research · May 10, 2023

5 Sector ETFs That Beat the Market in AprilWall Street wrapped up a winning April buoyed by better-than-expected earnings and easing of banking fears. Cooling inflation added to the strength. The Dow Jones logged its best monthly gain since January, rising 1.7%, while the S&P 500 rose 1.5%.Zacks Investment Research · May 2, 2023

5 Best ETF Areas of April Up At Least 10%April brings with it seasonal tailwinds for the equity world. Digital Assets, Sugar, Platinum, Biotech and Homebuilding were clear winners in the month.Zacks Investment Research · May 2, 2023

to start trading

SB

SBIOALPS Medical Breakthroughs ETF

SBIO

Pay with—

Available Balance0.00

Your PositionYou don't own any SBIO yet.

Related Tickers

Earnings